UPDATE 2-Lundbeck says Alzheimer's drug fails in late-stage study
September 22, 2016 at 15:33 PM EDT
Sept 22 (Reuters) - Danish drugmaker H Lundbeck A/S's highly anticipated experimental Alzheimer's drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating memory-robbing disease.
